Original paper
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Abstract
There are no US Food and Drug Administration-approved therapies for neonatal seizures. Phenobarbital and phenytoin frequently fail to control seizures. There are concerns about the safety of seizure medications in the developing brain. Levetiracetam has proven efficacy and an excellent safety profile in older patients; therefore, there is great interest in its use in neonates. However, randomized studies have not been performed. Our objectives...
Paper Details
Title
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial
Published Date
May 8, 2020
Journal
Volume
145
Issue
6